GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (XCNQ:BRAX) » Definitions » ROIC %

Braxia Scientific (XCNQ:BRAX) ROIC % : -149.34% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Braxia Scientific ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Braxia Scientific's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2023 was -149.34%.

As of today (2024-05-27), Braxia Scientific's WACC % is 14.65%. Braxia Scientific's ROIC % is -128.26% (calculated using TTM income statement data). Braxia Scientific earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Braxia Scientific ROIC % Historical Data

The historical data trend for Braxia Scientific's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Braxia Scientific ROIC % Chart

Braxia Scientific Annual Data
Trend Mar21 Mar22 Mar23
ROIC %
-141.08 -145.34 -337.90

Braxia Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -113.59 -186.44 -159.07 -48.63 -149.34

Competitive Comparison of Braxia Scientific's ROIC %

For the Biotechnology subindustry, Braxia Scientific's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Braxia Scientific's ROIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Braxia Scientific's ROIC % distribution charts can be found below:

* The bar in red indicates where Braxia Scientific's ROIC % falls into.



Braxia Scientific ROIC % Calculation

Braxia Scientific's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Mar. 2023 is calculated as:

ROIC % (A: Mar. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2022 ) + Invested Capital (A: Mar. 2023 ))/ count )
=-7.431 * ( 1 - 1.1% )/( (2.321 + 2.029)/ 2 )
=-7.349259/2.175
=-337.90 %

where

Braxia Scientific's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2023 is calculated as:

ROIC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-3.428 * ( 1 - 0% )/( (2.333 + 2.258)/ 2 )
=-3.428/2.2955
=-149.34 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Braxia Scientific  (XCNQ:BRAX) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Braxia Scientific's WACC % is 14.65%. Braxia Scientific's ROIC % is -128.26% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Braxia Scientific ROIC % Related Terms

Thank you for viewing the detailed overview of Braxia Scientific's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Braxia Scientific (XCNQ:BRAX) Business Description

Traded in Other Exchanges
Address
700 Bay Street, Suite 1903, Toronto, ON, CAN, M5G 1Z6
Braxia Scientific Corp is a research-driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as depressive disorder among others. It is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.

Braxia Scientific (XCNQ:BRAX) Headlines

No Headlines